Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04472260 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Verticalization of the Patient With Acute Respiratory Distress Syndrome: Assessment of Feasibility and Safety.

Study acronym: STAND_ARDS1
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 30, 2025 (before its estimated July 14, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Re-verified, no change to tracked fieldsv10
  2. Notable Primary and study completion dates: Oct 14, 2025 to Jul 14, 2026v9
  3. Notable Primary and study completion dates: Oct 15, 2024 to Oct 14, 2025v8
  4. Notable Primary and study completion dates: Oct 15, 2023 to Oct 15, 2024v7
  5. Notable Primary and study completion dates: Oct 15, 2022 to Oct 15, 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary and study completion dates: Sep 2022 to Oct 15, 2022
    • Start date changed from estimate of Sep 2021 to Oct 15, 2021
    v5
  2. Notable Start date: Apr 2021 to Sep 2021
    • Primary and study completion dates: Apr 2022 to Sep 2022
    v4
  3. Notable Start date: Jan 2021 to Apr 2021
    • Primary and study completion dates: Dec 2022 to Apr 2022
    v3
  4. Notable Primary and study completion dates: Jul 2021 to Dec 2022
    • Start date: Aug 2020 to Jan 2021
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute Respiratory Distress Syndrome (ARDS) is defined according to the Berlin definition (1) as diffuse lung damage occurring in patients with a predisposing risk factor. Positioning in the prone position (PP) has been shown to decrease mortality in patients with moderate to severe ARDS. However, this technique is not without deleterious effects such as ventilator-associated pneumonia, endotracheal tube obstruction, development of pressure ulcers, and increased workload for the caregivers. There are other positioning techniques such as the "upright" position, which simulates a relative verticality, which allows to increase the effects of the prone position and even in some patients to improve oxygenation without the PP in the acute phase of ARDS. However, given the revolution caused by the use of PP in ARDS patients, verticalization have not been studied in more details. Today, there is a bed on the market that allows patients to be truly upright without having to transfer them to a tilt table. The investigators believe that raising ARDS patients in the acute phase is safe and feasible in routine practice. In this research protocol comparing PP and verticalization in a crossover trial design in acute ARDS patients, the investigators want to show that this technique can be safe and feasible, with the same effects on oxygenation as PP.
Trial Details
NCT Number NCT04472260
Lead Sponsor Centre Hospitalier Régional d'Orléans
Conditions
(from sponsor)
Acute Respiratory Distress Syndrome, Prone Position
Related terms Respiratory Distress Syndrome
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov